| Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi, C Chen, ... Nature communications 10 (1), 1-20, 2019 | 293 | 2019 |
| Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages I Kadiu, P Narayanasamy, PK Dash, W Zhang, HE Gendelman The Journal of Immunology 189 (2), 744-754, 2012 | 240 | 2012 |
| Loss of neuronal integrity during progressive HIV-1 infection of humanized mice PK Dash, S Gorantla, HE Gendelman, J Knibbe, GP Casale, E Makarov, ... Journal of Neuroscience 31 (9), 3148-3157, 2011 | 129 | 2011 |
| Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice PK Dash, HE Gendelman, U Roy, S Balkundi, Y Alnouti, RL Mosley, ... Aids 26 (17), 2135-2144, 2012 | 122 | 2012 |
| Creation of a long-acting nanoformulated dolutegravir B Sillman, AN Bade, PK Dash, B Bhargavan, T Kocher, S Mathews, H Su, ... Nature communications 9 (1), 443, 2018 | 111 | 2018 |
| Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles T Zhou, H Su, P Dash, Z Lin, BLD Shetty, T Kocher, A Szlachetka, ... Biomaterials 151, 53-65, 2018 | 94 | 2018 |
| Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India NB Siddappa, PK Dash, A Mahadevan, N Jayasuryan, F Hu, B Dice, ... Journal of clinical microbiology 42 (6), 2742-2751, 2004 | 74 | 2004 |
| Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations P Puligujja, SS Balkundi, LM Kendrick, HM Baldridge, JR Hilaire, ... Biomaterials 41, 141-150, 2015 | 72 | 2015 |
| Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1–infected human peripheral blood lymphocyte–reconstituted mice U Roy, JE McMillan, Y Alnouti, N Gautum, N Smith, S Balkundi, P Dash, ... The Journal of infectious diseases 206 (10), 1577-1588, 2012 | 71 | 2012 |
| Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice MD Boska, PK Dash, J Knibbe, AA Epstein, SP Akhter, N Fields, R High, ... Molecular neurodegeneration 9, 1-18, 2014 | 61 | 2014 |
| Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs DP Gnanadhas, PK Dash, B Sillman, AN Bade, Z Lin, DL Palandri, ... The Journal of clinical investigation 127 (3), 857-873, 2017 | 57 | 2017 |
| Neuroprotective activities of CEP-1347 in models of neuroAIDS D Eggert, PK Dash, S Gorantla, H Dou, G Schifitto, SB Maggirwar, ... The journal of immunology 184 (2), 746-756, 2010 | 54 | 2010 |
| HIV-1 Tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1 C Bethel-Brown, H Yao, S Callen, YH Lee, PK Dash, A Kumar, S Buch The Journal of Immunology 186 (7), 4119-4129, 2011 | 49 | 2011 |
| Multimodal theranostic nanoformulations permit magnetic resonance bioimaging of antiretroviral drug particle tissue-cell biodistribution BD Kevadiya, C Woldstad, BM Ottemann, P Dash, BR Sajja, B Lamberty, ... Theranostics 8 (1), 256, 2018 | 47 | 2018 |
| Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection AA Epstein, P Narayanasamy, PK Dash, R High, SPR Bathena, ... Journal of Neuroimmune Pharmacology 8, 1224-1238, 2013 | 42 | 2013 |
| The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy G Zhang, D Guo, PK Dash, M Araínga, JL Wiederin, NA Haverland, ... Nanomedicine: Nanotechnology, Biology and Medicine 12 (1), 109-122, 2016 | 41 | 2016 |
| HIV-1 infection induces acetylation of NPM1 that facilitates Tat localization and enhances viral transactivation SS Gadad, RE Rajan, P Senapati, S Chatterjee, J Shandilya, PK Dash, ... Journal of molecular biology 410 (5), 997-1007, 2011 | 37 | 2011 |
| Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders D Eggert, PK Dash, N Serradji, CZ Dong, P Clayette, F Heymans, H Dou, ... Journal of neuroimmunology 213 (1-2), 47-59, 2009 | 37 | 2009 |
| Identification of unique B/C recombinant strains of HIV-1 in the southern state of Karnataka, India NB Siddappa, PK Dash, A Mahadevan, A Desai, N Jayasuryan, V Ravi, ... Aids 19 (13), 1426-1429, 2005 | 31 | 2005 |
| Creation of a long-acting rilpivirine prodrug nanoformulation JR Hilaire, AN Bade, B Sillman, N Gautam, J Herskovitz, BLD Shetty, ... Journal of controlled release 311, 201-211, 2019 | 30 | 2019 |
Larisa PoluektovaUniversity of Nebraska Medical CenterDirección de correo verificada de unmc.edu
